A cannabis operator in the US market announced on Tuesday (August 7) to shareholders it will increase its production capacity of cannabis in the state of Florida.

Liberty Health Sciences (CSE:LHS) offered an update to investors revealing it obtained permission to begin the production at its touted 360 Campus facility, despite a current retrofit taking place.


The company estimates it will increase its production capacity to nearly 225,000 square feet by early 2019 after completing the retrofit program which will add 80,000 square feet of production.

George Scorsis, CEO of Liberty Health said this new expansion, located in Gainesville, is a direct response from the company to the increased demand of medical cannabis in the state.

As part of the expansion, Liberty Health will also set up five new medical centers across the state and announced all of its delivery hub services will have a turnaround of 24 hours or less across the state.

Users of Liberty Health will now get text message alerts when the delivery is near them, similar to modern food delivery apps. Liberty Health says this strategy will keep customers informed, improve on the delivery anticipation and reduce failed deliveries.

The 360 Campus facility from Liberty Health will add the production capacity for the company from a current 21,200 square feet to 41,200.

Florida market gains steam among cannabis operators

The southern state legalized cannabis for medical use in 2017 after a successful vote in the 2016 election ballot. Momentum for a recreational vote for the state is increasing as well.

According to iAnthus Capital Holdings’ (CSE:IAN), another cannabis operator with assets in Florida reported in its first quarter 2018 results $15,783 in revenue, as it was the first quarter the company was available in the state.

The cannabis operator signed leases for a total aggregate retail space of 13,500 square feet across four cities in Florida.

In July, Scythian Biosciences (TSXV:SCYB) revealed its intentions to enter the Florida market as well thanks to the acquisition of CanCure Investments, a company in the process of acquiring a stake in Florida producer 3 Boys Farms.

Scythian’s CEO, Rob Reid, said in the statement he viewed Florida as one of the “largest and fastest growing” medical cannabis market in the US.

The move from Scythian will cause the company to migrate its stock from the TSX Venture Exchange (CSE) into the more US-favorable Canadian Securities Exchange (CSE).

Investor takeaway

Stock for Liberty Health closed at a price of C$0.85 per share during Tuesday’s s trading session, indicating a 3.66 percent increase in value.

Fellow active Florida operator iAnthus reacted positively today with a 1.98 percent increase in value to its stock, reaching a closing price of C$7.22.

Don’t forget to follow us @INN_Cannabis for real-time news updates! 

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less